| 1 | Wheat allergy: diagnosis and management (10.2147/jaa.s81550) | Abstract References ORCID | 175.38 | 217 |
| 2 | Animal models of asthma: utility and limitations (10.2147/jaa.s121092) | Abstract References ORCID | 173.38 | 204 |
| 3 | United airway disease: current perspectives (10.2147/jaa.s81541) | Abstract References ORCID | 169.15 | 179 |
| 4 | <p>Treatment Adherence in Adolescents with Asthma</… (10.2147/jaa.s233268) | Abstract References ORCID | 158.55 | 129 |
| 5 | Update on the role of alternatively activated macrophages in… (10.2147/jaa.s104508) | Abstract References ORCID | 158.29 | 128 |
| 6 | Dupilumab: a novel treatment for asthma (10.2147/jaa.s52387) | Abstract References ORCID | 152.81 | 108 |
| 7 | Underuse of epinephrine for the treatment of anaphylaxis: mi… (10.2147/jaa.s159400) | Abstract References ORCID | 150.65 | 101 |
| 8 | Current perspectives on tree nut allergy: a review (10.2147/jaa.s141636) | Abstract References ORCID | 150.00 | 99 |
| 9 | Leukotriene receptor antagonists in monotherapy or in combin… (10.2147/jaa.s3236) | Abstract References ORCID License | 149.14 | 30 |
| 10 | Non-eosinophilic asthma: current perspectives (10.2147/jaa.s153097) | Abstract References ORCID | 148.33 | 94 |
| 11 | Para-phenylenediamine allergy: current perspectives on diagn… (10.2147/jaa.s90265) | Abstract References ORCID | 146.20 | 88 |
| 12 | <p>NSAID-induced reactions: classification, prevalence… (10.2147/jaa.s164806) | Abstract References ORCID | 143.14 | 80 |
| 13 | Benralizumab: a unique IL-5 inhibitor for severe asthma (10.2147/jaa.s78049) | Abstract References ORCID | 141.91 | 77 |
| 14 | Clinical update on the use of biomarkers of airway inflammat… (10.2147/jaa.s15081) | Abstract References ORCID | 134.95 | 62 |
| 15 | Chronic hypersensitivity pneumonitis (10.2147/jaa.s81540) | Abstract References ORCID | 134.95 | 62 |
| 16 | Metabolism of ciclesonide in the upper and lower airways: re… (10.2147/jaa.s4051) | Abstract References ORCID License | 134.24 | 21 |
| 17 | Adverse outcomes from initiation of systemic corticosteroids… (10.2147/jaa.s176026) | Abstract References | 131.62 | 428 |
| 18 | Update on optimal use of omalizumab in management of asthma (10.2147/jaa.s14520) | Abstract References ORCID | 131.11 | 55 |
| 19 | Historical cohort study examining comparative effectiveness… (10.2147/jaa.s111170) | Abstract References ORCID | 129.32 | 52 |
| 20 | <p>Therapeutic Potential of Lebrikizumab in the Treatm… (10.2147/jaa.s211032) | Abstract References ORCID | 128.70 | 51 |
| 21 | Allergic bronchopulmonary aspergillosis treated successfully… (10.2147/jaa.s34579) | Abstract References ORCID | 126.09 | 47 |
| 22 | Factors predicting persistence of early wheezing through chi… (10.2147/jaa.s128319) | Abstract References ORCID | 125.41 | 46 |
| 23 | Profile of anti-IL-5 mAb mepolizumab in the treatment of sev… (10.2147/jaa.s40244) | Abstract References ORCID | 124.71 | 45 |
| 24 | Food protein-induced enterocolitis syndrome &ndash; a re… (10.2147/jaa.s100379) | Abstract References ORCID | 123.99 | 44 |
| 25 | Nasal polyps in patients with asthma: prevalence, impact, an… (10.2147/jaa.s86251) | Abstract References ORCID | 123.99 | 44 |
| 26 | Evaluating asthma websites using the Brief DISCERN instrumen… (10.2147/jaa.s133536) | Abstract References ORCID | 120.96 | 40 |
| 27 | Omalizumab for severe asthma: toward personalized treatment… (10.2147/jaa.s107982) | Abstract References ORCID | 120.15 | 39 |
| 28 | Predicting frequent asthma exacerbations using blood eosinop… (10.2147/jaa.s97973) | Abstract References ORCID | 120.15 | 39 |
| 29 | Lung penetration and patient adherence considerations in the… (10.2147/jaa.s14743) | Abstract References ORCID | 118.48 | 37 |
| 30 | Smoking cessation strategies for patients with asthma: impro… (10.2147/jaa.s85615) | Abstract References ORCID | 117.62 | 36 |
| 31 | Introduction of Asthma APGAR tools improve asthma management… (10.2147/jaa.s3595) | Abstract References ORCID License | 117.61 | 14 |
| 32 | Peak inspiratory flow rate measurement by using In-Check DIA… (10.2147/jaa.s127580) | Abstract References ORCID | 116.72 | 35 |
| 33 | Aquagenic urticaria: diagnostic and management challenges (10.2147/jaa.s91505) | Abstract References ORCID | 116.72 | 35 |
| 34 | <p>Intraoperative anaphylaxis to gelatin-based hemosta… (10.2147/jaa.s202784) | Abstract References ORCID | 115.81 | 34 |
| 35 | Comparison of the robustness and functionality of three adre… (10.2147/jaa.s33688) | Abstract References ORCID | 115.81 | 34 |
| 36 | Assessing the association between omalizumab and arteriothro… (10.2147/jaa.s29811) | Abstract References ORCID | 114.86 | 33 |
| 37 | Treatment of moderate to severe asthma: patient perspectives… (10.2147/jaa.s4214) | Abstract References ORCID | 114.86 | 33 |
| 38 | Selective p38&alpha; mitogen-activated protein kinase in… (10.2147/jaa.s4199) | Abstract References ORCID License | 114.61 | 13 |
| 39 | Training and administration of epinephrine auto-injectors fo… (10.2147/jaa.s106567) | Abstract References ORCID | 113.89 | 32 |
| 40 | Educational and behavioral interventions for asthma: who ach… (10.2147/jaa.s14772) | Abstract References ORCID | 113.89 | 32 |
| 41 | Diagnosis and management of eosinophilic asthma: a US perspe… (10.2147/jaa.s39119) | Abstract References ORCID | 113.89 | 32 |
| 42 | Aspirin-exacerbated respiratory disease: pathophysiological… (10.2147/jaa.s88739) | Abstract References ORCID | 113.89 | 32 |
| 43 | Asthma and obesity: does weight loss improve asthma control?… (10.2147/jaa.s32232) | Abstract References ORCID | 112.89 | 31 |
| 44 | The successful treatment of vocal cord dysfunction with low-… (10.2147/jaa.s6673) | Abstract References ORCID | 112.89 | 31 |
| 45 | Diagnosis of exercise-induced anaphylaxis: current insights (10.2147/jaa.s109105) | Abstract References ORCID | 111.85 | 30 |
| 46 | Risk factors for asthma and allergic diseases in school chil… (10.2147/jaa.s3844) | Abstract References ORCID License | 111.39 | 12 |
| 47 | Environmental triggers and avoidance in the management of as… (10.2147/jaa.s121276) | Abstract References | 107.61 | 141 |
| 48 | Potential role of histamine releasing factor (HRF) as a ther… (10.2147/jaa.s28868) | Abstract References ORCID | 107.35 | 26 |
| 49 | A multicenter evaluation of the efficacy and duration of act… (10.2147/jaa.s38671) | Abstract References ORCID | 107.35 | 26 |
| 50 | Dietary pattern and asthma: a systematic review and meta-ana… (10.2147/jaa.s49960) | Abstract References ORCID | 104.85 | 24 |